Cite
HARVARD Citation
Di Prospero, N. et al. (2021). Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study. Clinical obesity. 11 (2), p. n/a. [Online].